Leyre Zubiri

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

3.8DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more

Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00278-x

N/A

2.3DataRank · unranked

102 citations

Wenxin Chen, Sara Khattab, Katie Roster, Nga Nguyen, Boshen Yan +14 more

The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients

Annals of Oncology(2021)10.1016/j.annonc.2021.05.357

N/A

2.0DataRank · unranked

42 citations

Donald F. Chute, Ian A. Strohbehn, Sophia Zhao, Michelle Rengarajan, Alexander T. Faje +13 more

Pericardial disease in patients treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002771

N/A

0.668DataRank · unranked

85 citations

Zsófia D. Drobni, Amna Zafar, Thiago Quinaglia, Sarah Hartmann, Hannah Gilman +11 more

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2022.12.048

N/A

0.663DataRank · unranked

82 citations

Kimberly Tang, Guihong Wan, Nga Nguyen, Chenyue Lu, Pearl Ugwu‐Dike +20 more

Immune checkpoint inhibitors for cancer and venous thromboembolic events

European Journal of Cancer(2021)10.1016/j.ejca.2021.09.010

N/A

0.661DataRank · unranked

81 citations

Zsófia D. Drobni, Raza M. Alvi, Sean Murphy, Ryan J. Sullivan, Sarah Hartmann +11 more

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001935

N/A

0.657DataRank · unranked

79 citations

William S. Murphy, Shannon Wongvibulsin, Vartan Pahalyants, Kun‐Hsing Yu, Chenyue Lu +8 more

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002007

N/A

0.657DataRank · unranked

79 citations

Malek Hassan, Amna Zafar, Raza M. Alvi, Magid Awadalla, Syed Mahmood +35 more

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American Heart Association(2020)10.1161/jaha.120.018306

N/A

0.646DataRank · unranked

73 citations

Amna Zafar, Leyre Zubiri, Daniel A. Zlotoff, Raza M. Alvi, Charlotte Lee +10 more

Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors

Nephrology Dialysis Transplantation(2020)10.1093/ndt/gfaa272

N/A

0.617DataRank · unranked

60 citations

Nifasha Rusibamayila, Donald F. Chute, Meghan Lee, Ian A. Strohbehn, Leyre Zubiri +5 more

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.15.557794

N/A

0.607DataRank · unranked

12 citations

Daniel A. Zlotoff, Neal P. Smith, Isabela Kernin, Swetha Ramesh, Leyre Zubiri +31 more

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors

European Journal of Cancer(2022)10.1016/j.ejca.2021.12.024

N/A

0.581DataRank · unranked

47 citations

Olivier Michielin, Thiago Quinaglia, Daniel A. Zlotoff, Leyre Zubiri, Hannah Gilman +9 more

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007675

N/A

0.500DataRank · unranked

27 citations

Yevgeniy R. Semenov, Allireza Alloo, Daniel Q. Bach, Allison Betof Warner, Amina Bougrine +36 more

Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001329

N/A

0.457DataRank · unranked

20 citations

Meghan J. Mooradian, Florian J. Fintelmann, Leyre Zubiri, Donald F. Chute, Avinash Kambadakone +4 more

Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor–associated acute interstitial nephritis

Kidney International(2025)10.1016/j.kint.2025.05.029

N/A

0.434DataRank · unranked

17 citations

Kavita Mistry, Firasat M Alikhan, Sherley M. Mejia, Sagar Sadarangani, Andrew Cao +22 more

Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study

British Journal of Dermatology(2024)10.1093/bjd/ljae053

N/A

0.406DataRank · unranked

14 citations

Sara Khattab, Bonnie W. Leung, Shijia Zhang, Nga Nguyen, Matthew Tran +17 more

Tumor location as a risk factor for severe immune-related adverse events

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011312

N/A

0.312DataRank · unranked

7 citations

Ben Ouyang, Leyre Zubiri, Daniel Leonard, Kamil Slowikowski, Mike Wang +11 more

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study

medRxiv(2023)10.1101/2023.01.16.23284635

N/A

0.292DataRank · unranked

6 citations

Kimberly Tang, Guihong Wan, Nga Nguyen, Chenyue Lu, Pearl Ugwu‐Dike +20 more

Single-cell profiling of human heart and blood in immune checkpoint inhibitor-associated myocarditis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2507

N/A

0.165DataRank · unranked

2 citations

Daniel A. Zlotoff, Neal P. Smith, Swetha Ramesh, Isabela Kernin, Pritha Sen +15 more

Germline variants associated with immunotherapy-related adverse events

medRxiv(2022)10.1101/2022.04.10.22273627

N/A

0DataRank · unranked

0 citations

Sarah Abou Alaiwi, Wenxin Xu, Vivek Naranbhai, Amin H. Nassar, Ziad Bakouny +26 more

Immune checkpoint inhibitor–induced thyroiditis is a risk factor for acute and chronic kidney dysfunction

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab240

N/A

0DataRank · unranked

2 citations

Sarah E. Street, Donald F. Chute, Harish Seethapathy, Meghan Lee, Rituvanthikaa Seethapathy +7 more

Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors

Immunotherapy Advances(2021)10.1093/immadv/ltab014

N/A

0DataRank · unranked

22 citations

Sean Murphy, Raza M. Alvi, Charlotte Lee, Jingyi Gong, Ramya Mosarla +14 more

Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors

American Journal of Kidney Diseases(2021)10.1053/j.ajkd.2021.05.012

N/A

0DataRank · unranked

30 citations

Sophia Zhao, Ian A. Strohbehn, Nifasha Rusibamayila, Harish Seethapathy, Meghan Lee +9 more